Business Context and Reporting Period
This Form 6-K filing by Tiziana Life Sciences plc (the "Company") is dated March 29, 2021. The report serves to furnish a Regulatory News Service (RNS) announcement issued in the United Kingdom on the same date. The Company is a foreign private issuer headquartered in London, United Kingdom.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a corporate announcement and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document solely discloses a scheduled media event.
Guidance, Outlook, and Management Commentary
The primary content of this filing is the announcement that Gabriele Cerrone, Chairman of Tiziana Life Sciences, is scheduled to give an interview on Bloomberg Television US at 1:20 PM ET on March 29, 2021. The RNS Announcement is attached as Exhibit 99.1. The filing explicitly states that the information in the exhibit is furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that Section.
Key Facts for Investor Verification
- Event: Chairman Gabriele Cerrone interview on Bloomberg Television US.
- Date and Time: March 29, 2021, at 1:20 PM ET.
- Legal Status: The attached announcement is furnished, not filed, limiting its legal liability under Section 18 of the Exchange Act.
- Financial Data: No financial metrics are included in this specific filing; investors should refer to the Company's Form 20-F or other periodic reports for financial performance.